MorphoSys AG of Germany and Galápagos NV of Belgium have expanded a discovery alliance aimed at identifying new antibody targets in bone and joint diseases, to include a fourth target. Financial details weren’t disclosed. ---Subscribe to MedNous to access this article--- Company News
